CDC Recommends ZOSTAVAX®, Merck’s Shingles Vaccine, For All Appropriate Adults Aged 60 And Older
May 22nd 2008Drug InformationImmune System / Vaccines
The U.S. Centers for Disease Control and Prevention (CDC) has adopted the unanimous recommendation of its Advisory Committee on Immunization Practices (ACIP) for the use of ZOSTAVAX® (Zoster Vaccine Live) for the prevention of shingles in adults aged 60 and older. ZOSTAVAX is the only vaccine to prevent shingles, a frequently painful disease marked by a blistering rash that is caused by the reactivation of the chickenpox virus.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
